Novel therapeutic targets at the platelet vascular interface

LF Brass, L Zhu, TJ Stalker - Arteriosclerosis, thrombosis, and …, 2008 - Am Heart Assoc
LF Brass, L Zhu, TJ Stalker
Arteriosclerosis, thrombosis, and vascular biology, 2008Am Heart Assoc
Platelet activation in vivo can be part of the hemostatic response to injury or a pathological
response to disease. In either setting, platelets adhere to the vessel wall and to each other,
forming a closely packed mass interspersed with fibrin. Recent studies have identified new
molecules on the platelet surface and within platelets that support and regulate thrombus
growth and stability, ensuring that platelet accumulation after injury is sufficient to stop
bleeding, but not so exuberant that vascular occlusion occurs. An understanding of how this …
Platelet activation in vivo can be part of the hemostatic response to injury or a pathological response to disease. In either setting, platelets adhere to the vessel wall and to each other, forming a closely packed mass interspersed with fibrin. Recent studies have identified new molecules on the platelet surface and within platelets that support and regulate thrombus growth and stability, ensuring that platelet accumulation after injury is sufficient to stop bleeding, but not so exuberant that vascular occlusion occurs. An understanding of how this balance is achieved helps to illuminate the events of platelet activation and, at the same time, provides potential targets for new classes of antiplatelet agents.
Am Heart Assoc